This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pola, R. Articles by Fabra Fres, A. Search for Related Content Social Bookmarking                         What's this?

Polymer—Doxorubicin Conjugate with a Synthetic Peptide Ligand Targeted on Prostate Tumor

Institute of Macromolecular Chemistry v.v.i., Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic, pola{at}imc.cas.cz

Michal Pechar

Institute of Macromolecular Chemistry v.v.i., Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic

Karel Ulbrich

Institute of Macromolecular Chemistry v.v.i., Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic

Àngels Fabra Fres

Department of Cancer and Metastasis, Institut de Recerca Oncologica Hospital Duran y Reynals, Barcelona, Spain

In this study, the synthesis, physico-chemical characterization, and antiproliferative effects of a polymer—doxorubicin conjugate targeted by the amide of peptide sequence CPLHQRPMC are described. This sequence is discovered using the phage display method to achieve high affinity to prostate cancer cell line PC3MM2. The peptide is bound to N-(2-hydroxypropyl)methacrylamide-based copolymer carrier via a hydrophilic undeca(ethylene oxide) spacer. Doxorubicin is attached to the polymer using a pH-sensitive hydrazone bond which proves to be stable at a physiological pH 7.4 but quickly hydrolyzes at pH 5.0. The polymer—drug conjugate exhibits significant antiproliferative activity against human metastatic prostate cancer cell line PC3MM2 in vitro. The addition of a second polymer with the targeting peptide but without doxorubicin to the incubation media leads to a decrease in the cytotoxicity of 32% induced by the first polymer. This finding indicates a receptor-specific endocytosis of the polymeric drug.

Key Words: drug delivery systems • drug research • hydrazones • peptide targeting • polymers.

References

• Kopeek, J., Kopeková, P., Minko, T. and Lu, Z.R. (2000). HPMA Copolymer-anticancer Drug Conjugates: Design, Activity, and Mechanism of Action, Eur. J. Pharm. Biopharm., 50(1): 61—81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Monfardini, C. and Veronese, F.M. (1998). Stabilization of Substances in Circulation, Bioconjugate Chem., 9(4): 418—450.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Duncan, R. (2006). Polymer Conjugates as Anticancer Nanomedicines, Nat. Rev. Cancer, 6(9): 688—701.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Avichezer, D., Schechter, B. and Arnon, R. (1998). Functional Polymers in Drug Delivery: Carrier-supported CDDP (cis-platin) Complexes of Polycarboxylates — Effect on Human Ovarian Carcinoma, React. Funct. Polym., 36(1): 59—69.
• ubr, V., Strohalm, J., Hirano, T., Ito, Y. and Ulbrich, K. (1997). Poly [N-(2hydroxypropyl)methacrylamide] Conjugates of Methotrexate — Synthesis and in vitro Drug Release, J. Controlled Release, 49(2—3): 123—132.
• Putnam, D. and Kopeek, J. (1995). Enantioselective Release of 5-Fluorouracil from N-(2-Hydroxypropyl)Methacrylamide-Based Copolymers Via Lysosomal-Enzymes, Bioconjugate Chem., 6(4): 483—492.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Maeda, H. and Matsumura, Y. (1989). Tumoritropic and Lymphotropic Principles of Macromolecular Drugs, Crit. Rev. Ther. Drug Carrier Syst., 6(3): 193—210.[Web of Science][Medline] [Order article via Infotrieve]
• Maeda, H., Wu, J., Sawa, T., Matsumura, Y. and Hori, K. (2000). Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review, J. Controlled Release, 65(1—2): 271—284.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jaracz, S., Chen, J., Kuznetsova, L.V. and Ojima, L. (2005). Recent Advances in Tumor-targeting Anticancer Drug Conjugates, Bioorgan. Med. Chem., 13(17): 5043—5054.
• Chari, R.V.J., Jackel, K.A., Bourret, L.A., Derr, S.M., Tadayoni, B.M., Mattocks, K.M., Shah, S.A., Liu, C.N., Blattler, W.A. and Goldmacher, V.S. (1995). Enhancement of the Selectivity and Antitumor Efficacy of A Cc-1065 Analog through Immunoconjugate Formation, Cancer Res., 55(18): 4079—4084.[Abstract/Free Full Text]
• Chari, R.V.J. (1998). Targeted Delivery of Chemotherapeutics: Tumor-activated Prodrug Therapy, Adv. Drug Delivery Rev., 31(1—2): 89—104.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cohenuram, M. and Saif, M.W. (2007). Panitumumab the First Fully Human Monoclonal Antibody: from the Bench to the Clinic, Anti-cancer Drug, 18(1): 7—15.
• Shadidi, M. and Sioud, M. (2003). Selective Targeting of Cancer Cells using Synthetic Peptides, Drug Resist Update, 6(6): 363—371.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mori, T. (2004). Cancer-specific Ligands Identified from Screening of Peptide-display Libraries, Curr. Pharm. Des., 10(19): 2335—2343.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Alessi, P., Ebbinghaus, C. and Neri, D. (2004). Molecular Targeting of Angiogenesis, BBA-Rev Cancer, 1654(1): 39—49.
• Yamamoto, Y., Tsutsumi, Y. and Mayumi, T. (2002). Molecular Design of Bioconjugated Cell Adhesion Peptide with a Water-soluble Polymeric Modifier for Enhancement of Antimetastatic Effect, Curr. Drug Targets, 3(2): 123—130.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Aina, O.H., Sroka, T.C., Chen, M.L. and Lam, K.S. (2002). Therapeutic Cancer Targeting Peptides, Biopolymers, 66(3): 184—199.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kaiser, E., Colescot, R.L., Bossinge, C.D. and Cook, P.I. (1970). Kaiser's Test, Anal. Biochem., 34(2): 595.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vojkovsky, T. (1995). Chloranile Test, Pept. Res., 8(4): 236.[Web of Science][Medline] [Order article via Infotrieve]
• Guy, C.A. and Fields, G.B. (1997). Trifluoroacetic Acid Cleavage and Deprotection of Resin-bound Peptides Following Synthesis by Fmoc Chemistry, Methods Enzymol., 289(1): 67—83.[Web of Science][Medline] [Order article via Infotrieve]
• Ková, L., Strohalm, J., Chytil, P., Mrkvan, T., Ková, M., Hovorka, O., Ulbrich, K. and íhová, B. (2007). The Same Drug but a Different Mechanism of Action: Comparison of Free Doxorubicin with Two Different N-(2-Hydroxypropyl)methacrylamide Copolymer-Bound Doxorubicin Conjugates in EL-4 Cancer Cell Line, Bioconjugate Chem., 18(3): 894—902.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ulbrich, K., ubr, V., Strohalm, J., Plocová, D., Jelínková, M. and íhová, B. (2000). Polymeric Drugs Based on Conjugates of Synthetic and Natural Macromolecules I. Synthesis and Physico-chemical Characterisation, J. Controlled Release, 64(1—3): 63—79.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kissel, M., Peschke, P., ubr, V., Ulbrich, K., Schuhmacher, J., Debus, J. and Friedrich, E. (2001). Synthetic Macromolecular Drug Carriers: Biodistribution of Poly [(N-2-hydroxypropyl)methacrylamide] Copolymers and Their Accumulation in Solid Rat Tumors, PDA J. Pharm. Sci. Technol., 55(3): 191—201.[Abstract/Free Full Text]
• Mosmann, T. (1983). Rapid Colorimetric Assay for Cellular Growth and Survival — Application to Proliferation and Cyto-Toxicity Assays, J. Immunol. Methods, 65(1—2): 55—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sgouras, D. and Duncan, R. (1990). Methods for the Evaluation of Biocompatibility of Soluble Synthetic-Polymers Which Have Potential for Bio-Medical Use 1. Use of the Tetrazolium-Based Colorimetric Assay (Mtt) As A Preliminary Screen for Evaluation of Invitro Cytotoxicity, J. Mater. Sci.: Mater. Med., 1(2): 61—68.
• Etrych, T., Chytil, P., Jelínková, M., íhová, B. and Ulbrich, K. (2002). Synthesis of HPMA Copolymers Containing Doxorubicin Bound via a Hydrazone Linkage. Effect of Spacer on Drug Release and in vitro Cytotoxicity, Macromol. Biosci., 2(1): 43—52.[CrossRef][Web of Science]
• Rudolph, J., Theis, H., Hanke, R., Endermann, R., Johannsen, L. and Geschke, F.U. (2001). Seco-cyclothialidines: New Concise Synthesis, Inhibitory Activity toward Bacterial and Human DNA Topoisomerases, and Antibacterial Properties, J. Med. Chem., 44(4): 619—626.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Eleftheriou, S., Gatos, D., Panagopoulos, A., Stathopoulos, S. and Barlos, K. (1999). Attachment of Histidine, Histamine and Urocanic Acid to Resins of the Trityl-type, Tetrahedron Lett., 40(14): 2825—2828.[CrossRef][Web of Science]
• Seymour, L.W., Duncan, R., Strohalm, J. and Kopeek, J. (1987). Effect of Molecular-Weight (Mbarw) of N-(2-Hydroxypropyl)Methacrylamide Copolymers on Body Distribution and Rate of Excretion After Subcutaneous, Intraperitoneal, and Intravenous Administration to Rats, J. Biomed. Mater. Res., 21(11): 1341—1358.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K. and Kwon, G.S. (2000). Doxorubicin-loaded Poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) Copolymer Micelles: Their Pharmaceutical Characteristics and Biological Significance, J. Controlled Release, 64(1—3): 143—153.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hovorka, O., Etrych, T., ubr, V., Strohalm, J., Ulbrich, K. and íhová, B. (2006). HPMA Based Macromolecular Therapeutics: Internalization, Intracellular Pathway and Cell Death Depend on the Character of Covalent Bond between the Drug and the Peptidic Spacer and also on Spacer Composition, J. Drug Target, 14(6): 391—403.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• írová, M., Strohalm, J., ubr, V., Plocová, D., Rossmann, P., Mrkvan, T., Ulbrich, K. and íhová, B. (2007). Treatment with HPMA Copolymer-based Doxorubicin Conjugate Containing Human Immunoglobulin Induces Long-lasting Systemic Anti-tumour Immunity in Mice, Cancer Immunol. Immunother1., 56(1): 35—47.
• Chytil, P., Etrych, T., Koák, C., írová, M., Mrkvan, T., íhová, B. and Ulbrich, K. (2006). Properties of HPMA Copolymer-doxorubicin Conjugates with pH-controlled Activation: Effect of Polymer Chain Modification, J. Controlled Release, 115(1): 26—36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Floyd, J.D., Nguyen, D.T., Lobins, R.L., Bashir, Q., Doll, D.C. and Perry, M.C. (2005). Cardiotoxicity of Cancer Therapy, J. Clin. Oncol., 23(30): 7685—7696.[Abstract/Free Full Text]

Journal of Bioactive and Compatible Polymers, Vol. 22, No. 6, 602-620 (2007)
DOI: 10.1177/0883911507084423


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pola, R. Articles by Fabra Fres, A. Search for Related Content Social Bookmarking                         What's this?